Concord Healthcare Grp Co Ltd (2453.HK) Comparison with companies in other sectors?

Concord Healthcare Grp Co Ltd has a share price of 824.46M. You can analyze Concord Healthcare Grp Co Ltd (2453.HK) competitors across different market sectors through stock heatmaps.

What are 2453.HK's NET and operating margins?

Concord Healthcare Grp Co Ltd (2453.HK) operating margin is around -0.96, and net profit margin is approximately -1.14 as of the latest reports.

In what way does 2453.HK's earnings per share (EPS) trend reflect its financial momentum?

Concord Healthcare Grp Co Ltd (2453.HK) EPS is -0.68 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Concord Healthcare Grp Co Ltd is -8.21, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Concord Healthcare Grp Co Ltd?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Concord Healthcare Grp Co Ltd like P/E which is -8.28, P/B which is 2.23, and PEG which is -1.04. Compare them with sector averages to evaluate if the stock is priced fairly.

Concord Healthcare Grp Co Ltd

2453.HK•HKSE

Healthcare

Medical - Care Facilities

HK$5.58

HK$0.010(0.18%)

Concord Healthcare Grp Co Ltd (2453.HK) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.68

P/E Ratio

-8.21

ROE

-0.25%

Net Margin

-1.14%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$4.60B

Shares OutstandingTotal number of shares issued

$824.46M

Book Value/ShareNet worth per share

$2.65

Revenue/ShareAnnual revenue per share

$0.54

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.68

Net MarginNet income as percentage of revenue

-114.14%

Operating MarginOperating income as percentage of revenue

-95.59%

ROEReturn on shareholders' equity

-24.94%

ROAReturn on total assets

-7.50%

ROCEReturn on capital employed

-7.78%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.26

Cash/ShareCash and equivalents per share

$0.47

FCF YieldFree cash flow as percentage of market cap

-4.40%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for 2453.HKFinancial Ratios Analysis details for 2453.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 2453.HKSector Benchmarking details for 2453.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Concord Healthcare Grp Co Ltd Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Concord Healthcare Grp Co Ltd. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Concord Healthcare Grp Co Ltd's unique business strengths and challenges.

Key Financial Metrics for Concord Healthcare Grp Co Ltd

For Concord Healthcare Grp Co Ltd, essential financial indicators include EPS -0.68, PE -8.21, and ROE -0.25. These key ratios reveal insights into Concord Healthcare Grp Co Ltd's profitability, valuation, and operational health. Understanding these metrics enables you to compare Concord Healthcare Grp Co Ltd with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Concord Healthcare Grp Co Ltd

Metrics like Net Margin -114.14% and ROA -7.50% shed light on how well Concord Healthcare Grp Co Ltd is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Concord Healthcare Grp Co Ltd can sustain its operations and continue growing in the future.

Valuation and Market Position of Concord Healthcare Grp Co Ltd

Using ratios such as P/B Ratio 2.23 and PEG Ratio -1.04, investors can assess whether Concord Healthcare Grp Co Ltd is appropriately valued based on its financials and growth potential. These figures, combined with Concord Healthcare Grp Co Ltd's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Concord Healthcare Grp Co Ltd

Financial health indicators, such as Debt/Equity Ratio 1.95 and Cash Flow $-0.26, provide a snapshot of Concord Healthcare Grp Co Ltd's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Concord Healthcare Grp Co Ltd, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Concord Healthcare Grp Co Ltd

Investing in Concord Healthcare Grp Co Ltd based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Concord Healthcare Grp Co Ltd focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;